Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism?

Area of Science:

• Endocrinology
• Metabolic Diseases
• Pharmacology

Background:

• Metformin is the established first-line treatment for type 2 diabetes since the UK Prospective Diabetes Study (UKPDS).
• Emerging evidence suggests metformin offers protection against various comorbidities, including cardiovascular, renal, neurological, and neoplastic diseases.
• The precise mechanisms underlying metformin's protective effects are still under investigation.

Purpose of the Study:

• To explore the role of lactate metabolism in metformin's potential protective effects.
• To propose lactate production and oxidation as a key mechanism for metformin's benefits.
• To re-evaluate the perception of metformin-induced lactate production from a risk to a potential therapeutic benefit.

Main Methods:

• Review of existing literature on metformin's mechanism of action and lactate metabolism.
• Analysis of studies suggesting metformin's protective effects on various organ systems.
• Hypothesizing the role of lactate as an energy shuttle in mediating metformin's actions.

Main Results:

• Metformin demonstrably increases lactate production, concentration, and potentially oxidation.
• Lactate functions as a crucial energy shuttle, supplying energy to end organs.
• This lactate redistribution may bypass glycolysis, providing direct energy to organs.

Conclusions:

• Metformin-induced lactate production and subsequent oxidation may be a beneficial mechanism, not solely a risk.
• This pathway could explain metformin's protective effects on the heart, kidneys, and brain.
• The antineoplastic actions of metformin may also be partly attributed to this lactate-mediated effect.